According to a recent market study published by Growth Market Reports, titled, “Global Enteral Feeding Devices Market is segmented into by product type, by age group, by end user, by application and by region: Size, Share, Trends and Opportunity Analysis, 2016-2031”, the market was valued at US$ 4,474.2 million in 2023 and is expected to grow at a growth rate of 5.9% by the year 2031.

An enteral feeding device is used to deliver nutrition directly to the stomach or intestines through a thin, flexible tube. Additionally, its known as tube feeding, enteral nutrition is administered to patients who cannot maintain adequate oral intake of food or nutrition to meet their nutritional needs.

Enteral feeding devices can be placed through the nose (nasogastric and nasojejunal tubes) or mouth (orogastric tubes) or surgically implanted into the stomach (gastrostomy tubes) or intestines (jejunostomy tubes).

The advantages of enteral nutrition over parenteral nutrition include safety, effectiveness, decreased risk of infection, decreased cost, prevention of gut atrophy, and preservation of the barrier function of the gut. Enteral feeding is used in various clinical settings, such as in patients with dysphagia (difficulty swallowing), critical illness, neurological disorders, or in young children or infants who require additional nutritional support.

Get Sample Report @

Enteral feeding devices are typically made of materials such as silicone or polyurethane, which are biocompatible and can be safely used for extended periods. The tubes can be connected to feeding bags or syringes, and the rate of feeding can be controlled using gravity, pumps, or other methods.

Based on product type, the enteral feeding devices market is segmented into enteral feeding tubes, enteral feeding pumps, enteral feeding bags, administration sets, enteral syringes, and consumables. The nasoenteric feeding tubes segment is anticipated to value at USD   585.0 Mn in 2031 owing to the growing demand for short-term feeding tubes due to their non-invasive nature, cost-effectiveness, and effectiveness in providing nutritional therapy to patients without the need for surgery.

On the basis of age group, the enteral feeding devices market is bifurcated into adults and pediatric. The pediatric segment was valued at USD 1200.6 million in 2022 and is projected to expand at a CAGR of 5.6% during the forecast period, owing to the high incidence of preterm births and genetic disorders in pediatric and neonatal patients. Preterm infants, especially those weighing less than 1,500 grams, require sufficient feeding support for optimal growth. Additionally, infants born with genetic disorders such as Prader-Willi Syndrome also necessitate enteral feeding through tubes, leading to an increased demand for enteral feeding therapies in neonates and infants. According to a WHO and UNICEF report, 152 million vulnerable babies are born too soon from 2010 to 2020.

Based on end user, the enteral feeding devices market is bifurcated into hospitals, home care settings, and ambulatory care settings. The home care settings segment was valued at USD   923.6 million in 2022 and is projected to expand at a CAGR of 6.1% during the forecast period, owing to a trend shift towards home-based enteral nutrition, driven by rising hospital costs and the need for cost-effective long-term nutritional solutions. Moreover, healthcare professionals increasingly recommend home enteral nutrition as a convenient and cost-effective option for patients requiring extended nutritional support, leading to increased sales of enteral feeding devices.

Based on application, the enteral feeding devices market is segmented into oncology, gastrointestinal diseases, neurological disorders, diabetes, hypermetabolism, critical care, and others. The gastrointestinal diseases segment was valued at USD   796.5 million in 2022 and is projected to expand at a CAGR of 6.0% during the forecast period, as patients with gastrointestinal diseases often experience difficulty in consuming adequate nutrition through oral intake. Enteral feeding devices provide a means to deliver essential nutrients and fluids directly to the stomach or small intestine, ensuring adequate nutrition for these patients. Therefore, it is expected to increase the demand for enteral feeding devices among the gastrointestinal patients.

The outbreak of Coronavirus disease in 2019 (COVID-19) restrained the global economy, created global interdependence, and challenged the governments of various nations. The pandemic raised concerns among economies and businesses by shifting focus to the online supply of medical drugs and devices. The COVID-19 outbreak affected almost every industry. The long-term effects of the pandemic are expected to affect the growth of various industries during the forecast period, especially across Eastern Europe, the European Union, Eastern & Central Asia, and the US.

COVID-19 led to unprecedented demand for medical devices, such as diagnostic testing, ventilators, and personal protective equipment (PPE). However, not all medical gadgets are necessary for managing patients during the pandemic. Elective medical treatments are being postponed or canceled during the pandemic, as hospitals prioritized treating COVID-19 patients, resulting in decreased demand for other items.

Medical device companies focused on immediate crisis response, keeping staff safe, ensuring business continuity, and dealing with the rapid changes in the healthcare ecosystem. This also included responding to fast shifts in care location and patient conduct.

Short-term planning impacted a company survival during the pandemic and shaped its long-term recovery for a potentially different future in the medical device business. Medical device firms have transformed the way they communicate with and serve their customers.

The majority of businesses prioritized new digital capabilities, such as online customer care people, webinars with key opinion leaders, and professional education, to facilitate digital touchpoints with their customers. Digital capabilities are easy to adopt for large and mid-sized organizations. Digital capabilities such as product demos and digital detailing have become commonplace in go-to-market strategies.

The Future of the Enteral Feeding Devices Market:

The future of the enteral feeding devices market is expected to be shaped by a combination of technological advancements, demographic changes, and shifts in healthcare policies. Advancements in technology, such as artificial intelligence and machine learning, are expected to improve the accuracy and efficiency of enteral feeding devices, while personalized nutrition plans tailored to individual patients' needs are also expected to become more prevalent. The trend towards home healthcare is likely to continue, driving demand for portable and convenient devices that can be used in the home setting. Patient safety is also expected to become a major focus, with devices designed with safety features such as automatic shut-off and tamper-evident caps becoming more common. Additionally, emerging markets such as Asia and Latin America are expected to create new opportunities for enteral feeding device manufacturers. Regulatory changes and a focus on sustainability are also likely to shape the market, with manufacturers expected to develop devices that are designed with sustainability in mind. Overall, the future of the enteral feeding devices market is likely to be marked by a focus on innovation, patient safety, and sustainability.

Market Key Developments

In December 2023, Fresenius SE & Co. KGaA and Mayo Clinic entered into multiyear supply and service agreement for the Ivenix infusion system. According to this agreement, Mayo Clinic is expected to purchase 10,000 Ivenix large-volume infusion pumps for its hospitals and clinics in Minnesota, Arizona, and Florida.

In November 2023, Fresenius SE & Co. KGaA announced the launch of its tocilizumab biosimilar Tyenne referencing RoActemra (tocilizumab) in the European Union.

In July 2022, Cardinal Health Inc announced that it has acquired the Bendcare group purchasing organization (CPO-GPO) entity and made a minority investment in the Bendcare management services organization (MSO). Following the acquisition of the CPO-GPO, current Bendcare-affiliated CPO-GPO members are expected to transition to Cardinal Health's Cornerstone Rheumatology.

In November 2023, BD launched a new and advanced ultrasound system designed to help improve clinician efficiency when placing peripherally inserted central catheters (PICCs), central venous catheters, IV lines, and other vascular access devices. The SiteRite 9 Ultrasound System is an all-in-one system designed with a user-friendly experience on an updated 15.6-inch touch screen with enhanced image quality. It supports clinicians during the vascular access device insertion process.

The players in the Global Enteral Feeding Devices Market include Fresenius SE & Co. KGaA; Avanos Medical, Inc; Danone; Nestlé; Cardinal Health Inc; BD; Baxter International Inc.; B. Braun SE; Moog Inc.; Vygon; Boston Scientific Corporation; CONMED Corporation; Medela; Cook Group; Dynarex Corporation and Others.

Report Metric


Market Value in 2023

USD 4,474.2 Million

Market Growth Rate (from 2023 to 2031)


Historical Data

2016 & 2022

Base Year


Forecast Period

2023 – 2031

Units Considered

Value (USD Million)

Market Segments

By Product Type, By Age Group, By End User, By Application

Key Companies Profiled

Fresenius SE & Co. KGaA; Avanos Medical, Inc; Danone; Nestlé; Cardinal Health Inc; BD; Baxter International Inc.; B. Braun SE; Moog Inc.; Vygon; Boston Scientific Corporation; CONMED Corporation; Medela; Cook Group; Dynarex Corporation and Others.

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail of tailor-made purchase options to meet your research requirements.

Target Audience:

  • Supply-side: Manufacturer, Suppliers and End-users.

  • Demand Side: Hospitals & Clinics, Dialysis Centers, Ambulatory Surgical Centers and Others.